Recent Finacing
Recent Raise
Pervasis Therapeutics is a clinical-stage biotech developing biologically active therapeutics, including PVS-10200 to restore vasculature after peripheral arterial interventions and Vascugel to prevent hemodialysis arteriovenous access failure.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
